Successful treatment of severe psoriasis relapse with secukinumab (interleukin 17 A inhibitor) after abrupt brodalumab (interleukin 17 receptor inhibitor) discontinuation: A retrospective study evaluating long-term efficacy and safety
2018 ◽
Vol 79
(4)
◽
pp. 758-760
◽
Keyword(s):
2019 ◽
Vol 29
(4)
◽
pp. 399-406
Keyword(s):
2014 ◽
Vol 51
(10)
◽
pp. 1076-1082
◽
2019 ◽
Vol 182
(3)
◽
pp. 605-617
◽
Keyword(s):
2016 ◽
Vol 111
◽
pp. S328
Keyword(s):
2016 ◽
Vol 10
(suppl 1)
◽
pp. S337.3-S338
Keyword(s):
2019 ◽
Vol 81
(4)
◽
pp. AB233
Keyword(s):
2012 ◽
Vol 66
(2)
◽
pp. 241-251
◽
Keyword(s):